The latest amendment to patent laws in India will increase healthcare costs over time and create opportunities along the entire healthcare value chain, according to a study. "The eventual increase in prices of drugs will make them less affordable to many Indians, which, in turn, could prove to be an opportunity for health insurance firms - both domestic and foreign," according to a study by research firm Evalueserve. "The new regime is expected to have an impact not only on the pharmaceuticals market, but also on the entire healthcare value chain. An increase in healthcare costs may prompt the entry of customized healthcare management firms in India in the near future," the study said. |